Peringkat dalam Saham
#38795
Agentix Corp., a company in the clinical development phase, specializes in the... Agentix Corp., a company in the clinical development phase, specializes in the discovery and commercialization of therapeutic agents aimed at treating metabolic disorders. Its pipeline includes two primary candidates: AGTX-2004, a peripherally-acting CB1 receptor antagonist, which has exhibited effectiveness in animal studies for both obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, also demonstrating positive results in animal models for obesity and non-alcoholic fatty liver diseases. The company was founded in 2013, initially known as FairWind Energy, Inc., before officially changing its name to Agentix Corp. in June 2019. Its operations are based in Dana Point, California.
Harga Saham
$0.02
Terakhir disinkronkan: 2026-08-13
Kapitalisasi Pasar
$801.34K
Perubahan (1 tahun)
-18.70%
Perdagangan Agentix Corp. (AGTX)
Harga AGTX dengan kapitalisasi pasar B
Kapitalisasi pasar dari Agentix Corp.(AGTX)
Kapitalisasi Pasar: $801.34K
Per August 2026, Agentix Corp. memiliki kapitalisasi pasar sebesar $801.34K. Ini menjadikan Agentix Corp. sebagai perusahaan 38795th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Agentix Corp. dari 2015 hingga 2026
AGTX dibandingkan dengan 5 teratas stocks paling populer
| Harga AGTX |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.444T
|
+679,351,813.10%
|
|
|
|
|
$4.484T
|
+559,551,215.14%
|
|
|
|
|
$4.166T
|
+519,941,900.80%
|
|
|
|
|
$3.700T
|
+461,750,631.31%
|
|
|
|
|
$2.839T
|
+354,229,950.95%
|
